Difficulty: Medium
Average Score: 87%
Practice
Which of the following barbiturates is a long acting barbiturate (i.e. has a longer onset and duration of action)
Correct answer
A
Rationale
In the context of the pharmacology of CNS drugs, understanding the characteristics of different barbiturates is crucial. In this question, the correct answer is A) Phenobarbital, as it is a long-acting barbiturate.
Phenobarbital has a longer onset and duration of action compared to the other options. This is due to its unique pharmacokinetic properties, including a longer half-life and slower metabolism in the body. This makes it suitable for use in conditions requiring sustained anticonvulsant effects, such as epilepsy.
Secobarbital and Amobarbital are short to intermediate-acting barbiturates, which have a faster onset and shorter duration of action. They are commonly used for sedation and anesthesia due to their rapid effects.
Choosing "All of the above" (Option D) is incorrect because not all the options listed are long-acting barbiturates. This demonstrates the importance of understanding the differences in pharmacokinetics among CNS drugs to make appropriate clinical decisions.
Educationally, this question highlights the significance of knowing the specific properties of different drugs within the same class to tailor treatment plans effectively. It reinforces the need for healthcare professionals to have a solid foundation in pharmacology to ensure safe and efficient patient care.
Phenobarbital has a longer onset and duration of action compared to the other options. This is due to its unique pharmacokinetic properties, including a longer half-life and slower metabolism in the body. This makes it suitable for use in conditions requiring sustained anticonvulsant effects, such as epilepsy.
Secobarbital and Amobarbital are short to intermediate-acting barbiturates, which have a faster onset and shorter duration of action. They are commonly used for sedation and anesthesia due to their rapid effects.
Choosing "All of the above" (Option D) is incorrect because not all the options listed are long-acting barbiturates. This demonstrates the importance of understanding the differences in pharmacokinetics among CNS drugs to make appropriate clinical decisions.
Educationally, this question highlights the significance of knowing the specific properties of different drugs within the same class to tailor treatment plans effectively. It reinforces the need for healthcare professionals to have a solid foundation in pharmacology to ensure safe and efficient patient care.